Who are Segesterone Acetate and Ethinyl Estradiol's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): oral contraceptive pills, Female Contraceptive, Etonogestrel/ethinyl estradiol vaginal ring, oral contraceptives, Contraceptive Vaginal Ring, Ortho Tri Cyclen.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/segesterone-acetate-and-ethinyl-estradiol.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Segesterone Acetate and Ethinyl Estradiol — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Segesterone Acetate and Ethinyl Estradiol (Segesterone Acetate and Ethinyl Estradiol) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hormonal contraceptive. Area: Contraception / Women's Health.

marketed Hormonal contraceptive Progesterone receptor (segesterone acetate); estrogen receptor (ethinyl estradiol) Contraception / Women's Health Small molecule Live · refreshed every 30 min

Target snapshot

Segesterone Acetate and Ethinyl Estradiol (Segesterone Acetate and Ethinyl Estradiol) — TherapeuticsMD. A progestin-estrogen combination that suppresses ovulation and alters cervical mucus and endometrial environment to prevent pregnancy.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Segesterone Acetate and Ethinyl Estradiol TARGET	Segesterone Acetate and Ethinyl Estradiol	TherapeuticsMD	marketed	Hormonal contraceptive	Progesterone receptor (segesterone acetate); estrogen receptor (ethinyl estradiol)
oral contraceptive pills	oral contraceptive pills	Kayseri Education and Research Hospital	marketed	Hormonal contraceptive	Estrogen receptor, Progesterone receptor
Female Contraceptive	Female Contraceptive	Italfarmaco	marketed	Hormonal contraceptive	Progesterone receptor, estrogen receptor
Etonogestrel/ethinyl estradiol vaginal ring	Etonogestrel/ethinyl estradiol vaginal ring	Andrea Roe, MD, MPH	marketed	Combined hormonal contraceptive	Progesterone receptor, estrogen receptor
oral contraceptives	oral contraceptives	FHI 360	marketed	Hormonal contraceptive	Estrogen receptor, Progesterone receptor
Contraceptive Vaginal Ring	Contraceptive Vaginal Ring	Penn State University	marketed	Hormonal contraceptive
Ortho Tri Cyclen	Ortho Tri Cyclen	Virginia Commonwealth University	marketed	Oral contraceptive (combined hormonal contraceptive)	Progesterone receptor, estrogen receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hormonal contraceptive class)

Penn State University · 2 drugs in this class
Italfarmaco · 1 drug in this class
Kayseri Education and Research Hospital · 1 drug in this class
TherapeuticsMD · 1 drug in this class
University of Alabama at Birmingham · 1 drug in this class
University of Athens · 1 drug in this class
FHI 360 · 1 drug in this class
University of Pittsburgh · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Segesterone Acetate and Ethinyl Estradiol — Competitive Intelligence Brief. https://druglandscape.com/ci/segesterone-acetate-and-ethinyl-estradiol. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab